Scientists behind COVID-19 vaccine will depart BioNTech

The company’s co-founders said they are leaving to start a new mRNA-based company.
Fierce Pharma

Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'

One of the most powerful voices in the biopharma industry, Pfizer CEO Albert Bourla, Ph.D., has weighed in with sharp ...

Pfizer CEO flags issues with FDA's vaccine leadership

Pfizer CEO ‌Albert ‌Bourla on Monday ​flagged issues with the leadership of ‌the ⁠U. Food and ⁠Drug Administration's vaccine ...

RFK Jr’s pick to review Covid vaccines authored misleading research, experts say

HHS calls MIT professor ‘more than qualified’ for advisory panel and calls ‘attacks’ on him ‘politically motivated’ ...
AOL

Pfizer to seek OK for 3rd vaccine dose; shots still protect

Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the ...

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...